Clinical Trials
ClinicalRM And Mapp Biopharmaceutical Combine Efforts To Continue The Fight Against Ebola
ClinicalRM will again deploy its boots-on-the-ground approach to fighting Ebola Virus Disease (EVD) with an expanded access protocol for ZMappTM, an investigational treatment for...
Packaging & Labelling
Sharp Packaging Services Selects TraceLink to Achieve DSCSA Compliance
Partnership will help Sharp Packaging Services eliminate point-to-point integration complexities and reduce business risk for its extensive pharmaceutical customer base. With...
Production & Manufacturing
Pfizer suspends work at Hospira India plant as FDA turns up heat
Pfizer is being schooled in the challenges of sterile drug manufacturing that come with its $15 billion buyout of Hospira. The New York drug...
Press Releases
Takeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in Relapsed/Refractory Multiple Myeloma
Takeda Pharmaceutical Company Limited announced Takeda Canada has received approval from Health Canada for NINLARO™ (ixazomib) capsules in combination with lenalidomide and dexamethasone for...
Press Releases
FDA Approves Mercks KEYTRUDA® for Patients with Recurrent or Metastatic Head and Neck Cancer
Merck known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the...
News
Valeant Pharmaceuticals Announces Licensing Agreement With Norgine B.V. For NER1006 In U.S. And Canada
Valeant Pharmaceuticals International, Inc announced that it has entered into a licensing agreement with Norgine B.V. ("Norgine"); under which Valeant has obtained the rights...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read